Pregled bibliografske jedinice broj: 86052
Iatrogenic Creutzfeldt-Jakob disease acquired with lyophilized dura mater graft
Iatrogenic Creutzfeldt-Jakob disease acquired with lyophilized dura mater graft // Abstracts of the 5th Congress of the European Society for Clinical Neuropharmacology ; u: Neurobiology of Aging / Paul D. Coleman (ur.).
Amsterdam: Elsevier, 2002. str. S68-S68 (poster, nije recenziran, sažetak, stručni)
CROSBI ID: 86052 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Iatrogenic Creutzfeldt-Jakob disease acquired with lyophilized dura mater graft
Autori
Liščić, Rajka ; Miklić, Pavle
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Abstracts of the 5th Congress of the European Society for Clinical Neuropharmacology ; u: Neurobiology of Aging
/ Paul D. Coleman - Amsterdam : Elsevier, 2002, S68-S68
Skup
Congress of the European Society for Clinical Neuropharmacology (5 ; 2000)
Mjesto i datum
Opatija, Hrvatska, 17.05.2000. - 21.05.2000
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
Prions; CJD; Dura graft
Sažetak
Creutzfeld-Jakob disease (CJD) is a lethal transmissible disorder. Prion protein is considered to be a transmissible agent. A 37-year-old patient with CJD is presented, who had received a cadaveric dura mater graft 12 years before the onset of neurologic symptoms. Pure collagen implant obtained from bovine pericardium, Lyoplant was used. Analysis of the prion protein (PrP) gene was performed on genomic DNA according to standard procedures. There was no mutation in the open reading frame. The PrP gene was homozygous for valin at the polymorphic codon 129. Cerebrospinal fluid analysis for 14-3-3 proteine was positive. Autopsy was not performed. It is reported on the first Croatian patient who most likely acquired CJD consequentially to the use of cadaveric dura mater graft. It is manifest that the awareness of iatrogenic transmission of CJD and adoption of preventive measures are the only effective way to stop the spread of CJD among surgically treated patients. Therefore, the use of autologous tissue or durapatch, a fully synthetic material of the implant, sterilized with ethylene oxide process, is recommended.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0022009
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE